Meredith Mills

3.0k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Meredith Mills is a scholar working on Genetics, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Meredith Mills has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 13 papers in Cancer Research and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Meredith Mills's work include BRCA gene mutations in cancer (23 papers), Cancer Genomics and Diagnostics (9 papers) and Genetic factors in colorectal cancer (6 papers). Meredith Mills is often cited by papers focused on BRCA gene mutations in cancer (23 papers), Cancer Genomics and Diagnostics (9 papers) and Genetic factors in colorectal cancer (6 papers). Meredith Mills collaborates with scholars based in United States, Canada and France. Meredith Mills's co-authors include Allison W. Kurian, James M. Ford, Yuya Kobayashi, Stephen E. Lincoln, Kerry Kingham, Uri Ladabaum, Lisa McPherson, Shelley M. Payne, Alice S. Whittemore and Shan Yang and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer.

In The Last Decade

Meredith Mills

32 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer

2022 154 citations Winston R. Becker, Stephanie Nevins et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meredith Mills United States	16	971	539	454	382	300	32	1.5k
Karin Kast Germany	15	556 0.6×	400 0.7×	394 0.9×	168 0.4×	361 1.2×	52	1.1k
Hilal Ünsal Türkiye	10	529 0.5×	348 0.6×	606 1.3×	181 0.5×	408 1.4×	20	1.2k
Ravindran Ankathil Malaysia	22	267 0.3×	251 0.5×	649 1.4×	131 0.3×	318 1.1×	99	1.3k
Paul A. Russell United Kingdom	18	1.1k 1.2×	369 0.7×	1.2k 2.6×	346 0.9×	384 1.3×	28	2.7k
Amit Sud United Kingdom	15	285 0.3×	161 0.3×	361 0.8×	211 0.6×	244 0.8×	37	962
Florentia Fostira Greece	14	416 0.4×	210 0.4×	434 1.0×	179 0.5×	245 0.8×	56	942
Melissa C. Larson United States	18	181 0.2×	177 0.3×	370 0.8×	206 0.5×	354 1.2×	77	1.0k
Allison Jones United Kingdom	25	306 0.3×	691 1.3×	1.5k 3.4×	65 0.2×	310 1.0×	47	2.1k
Anna Måsbäck Sweden	22	187 0.2×	362 0.7×	423 0.9×	145 0.4×	844 2.8×	48	1.8k
Luna Kadouri Israel	19	412 0.4×	248 0.5×	530 1.2×	107 0.3×	401 1.3×	56	1.1k

Countries citing papers authored by Meredith Mills

Since Specialization

Citations

This map shows the geographic impact of Meredith Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith Mills more than expected).

Fields of papers citing papers by Meredith Mills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith Mills. The network helps show where Meredith Mills may publish in the future.

Co-authorship network of co-authors of Meredith Mills

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith Mills. A scholar is included among the top collaborators of Meredith Mills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith Mills. Meredith Mills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

King, Daniel A., et al.. (2023). Therapeutic Implications of Oncogenic Missense HER2 (ERBB2) Mutations in Gastric Adenocarcinoma. JCO Precision Oncology. 7(7). e2200093–e2200093. 2 indexed citations

Becker, Winston R., Stephanie Nevins, Derek C. Chen, et al.. (2022). Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nature Genetics. 54(7). 985–995. 154 indexed citations breakdown →

Archer, Stephanie, Rozelle Laquindanum, Meredith Mills, et al.. (2022). Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial. Cancers. 14(11). 2716–2716. 10 indexed citations

Idos, Gregory, Allison W. Kurian, Charité Ricker, et al.. (2019). Preventive surgery after multiplex genetic panel testing (MGPT).. Journal of Clinical Oncology. 37(15_suppl). 1525–1525. 1 indexed citations

Caswell‐Jin, Jennifer L., Tanya Gupta, Evan Hall, et al.. (2017). Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genetics in Medicine. 20(2). 234–239. 126 indexed citations

Kurian, Allison W., Gregory Idos, Julie O. Culver, et al.. (2016). Safety of multiplex gene testing for inherited cancer risk: Interim analysis of a clinical trial.. Journal of Clinical Oncology. 34(15_suppl). 1503–1503. 3 indexed citations

Idos, Gregory, Allison W. Kurian, Charité Ricker, et al.. (2016). Yield of multiplex panel testing compared to expert opinion and validated prediction models.. Journal of Clinical Oncology. 34(15_suppl). 1509–1509. 2 indexed citations

Lincoln, Stephen E., Yuya Kobayashi, Michael J. Anderson, et al.. (2015). A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. Journal of Molecular Diagnostics. 17(5). 533–544. 146 indexed citations

Ellisen, Leif W., Allison W. Kurian, Meredith Mills, et al.. (2015). Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment.. Journal of Clinical Oncology. 33(15_suppl). 1513–1513. 1 indexed citations

10.

Kurian, Allison W., Emily E. Hare, Meredith Mills, et al.. (2014). Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. Journal of Clinical Oncology. 32(19). 2001–2009. 346 indexed citations

11.

Kurian, Allison W., Elizabeth Schackmann, Michael Smith, et al.. (2012). Online Tool to Guide Decisions forBRCA1/2Mutation Carriers. Journal of Clinical Oncology. 30(5). 497–506. 66 indexed citations

12.

Kwong, Ava, Benjamin A. Goldstein, Jafi A. Lipson, et al.. (2012). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. Familial Cancer. 11(3). 429–439. 22 indexed citations

13.

Schackmann, Elizabeth, et al.. (2012). Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers. Familial Cancer. 12(1). 65–73. 16 indexed citations

14.

Staton, Ashley D., Allison W. Kurian, Kristin Cobb, Meredith Mills, & James M. Ford. (2007). Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Familial Cancer. 7(2). 179–186. 57 indexed citations

15.

Kurian, Allison W., Nicolette M. Chun, Meredith Mills, et al.. (2007). BRCA1/2 mutations and cancer risk in Asian-Americans. Journal of Clinical Oncology. 25(18_suppl). 10512–10512. 1 indexed citations

16.

Ghanouni, Pejman, Allison W. Kurian, Daniel Margolis, et al.. (2007). Ductal Pattern Enhancement on Magnetic Resonance Imaging of the Breast Due to Ductal Lavage. The Breast Journal. 13(3). 281–286. 3 indexed citations

17.

Kurian, Allison W., Erich Schwartz, Meredith Mills, et al.. (2007). A phase II breast cancer chemoprevention study of lovastatin in high-risk women: Initial feasibility data. Journal of Clinical Oncology. 25(18_suppl). 1502–1502. 1 indexed citations

18.

Kurian, Allison W., Anne‐Renee Hartman, Meredith Mills, et al.. (2005). Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expectations. 8(3). 221–233. 15 indexed citations

19.

Hartman, Anne‐Renee, Bruce L. Daniel, Allison W. Kurian, et al.. (2004). Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer. 100(3). 479–489. 62 indexed citations

20.

Mills, Meredith, et al.. (1988). Elevated serum elastase and alpha-1-antitrypsin levels in hemolytic uremic syndrome.. PubMed. 30(4). 193–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact